Hormone Replacement Therapy

Study finds no association between HRT use and risk of lymphomas, myelomas

Published in Cancer Weekly, November 2nd, 2004

Pharmacologists in Italy have found no association between postmenopausal use of hormone replacement therapy (HRT) and risk of developing lymphomas and myelomas.

The existence of such a relationship "was analyzed using data from a case-control study conducted in northern Italy between 1983 and 1992," reported A. Altieri at the Mario Negri Institute of Pharmacology Research, and colleagues.

"Cases included 26 incident histologically confirmed, postmenopausal female patients of Hodgkin's disease (HD), 145 non-Hodgkin's lymphomas (NHL), and 65 multiple myelomas (MM), between 45 and 79 years of age. The control group comprised 361 women (age range 45-79...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-11-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry